1. Home
  2. FBIO vs HHS Comparison

FBIO vs HHS Comparison

Compare FBIO & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBIO
  • HHS
  • Stock Information
  • Founded
  • FBIO 2006
  • HHS 1923
  • Country
  • FBIO United States
  • HHS United States
  • Employees
  • FBIO N/A
  • HHS N/A
  • Industry
  • FBIO Biotechnology: Pharmaceutical Preparations
  • HHS Advertising
  • Sector
  • FBIO Health Care
  • HHS Consumer Discretionary
  • Exchange
  • FBIO Nasdaq
  • HHS Nasdaq
  • Market Cap
  • FBIO 39.4M
  • HHS 39.4M
  • IPO Year
  • FBIO N/A
  • HHS N/A
  • Fundamental
  • Price
  • FBIO $1.62
  • HHS $5.05
  • Analyst Decision
  • FBIO Strong Buy
  • HHS
  • Analyst Count
  • FBIO 3
  • HHS 0
  • Target Price
  • FBIO $18.00
  • HHS N/A
  • AVG Volume (30 Days)
  • FBIO 277.9K
  • HHS 17.3K
  • Earning Date
  • FBIO 03-27-2025
  • HHS 03-13-2025
  • Dividend Yield
  • FBIO N/A
  • HHS N/A
  • EPS Growth
  • FBIO N/A
  • HHS N/A
  • EPS
  • FBIO N/A
  • HHS N/A
  • Revenue
  • FBIO $81,501,000.00
  • HHS $187,604,000.00
  • Revenue This Year
  • FBIO N/A
  • HHS N/A
  • Revenue Next Year
  • FBIO $128.63
  • HHS $4.05
  • P/E Ratio
  • FBIO N/A
  • HHS N/A
  • Revenue Growth
  • FBIO 31.51
  • HHS N/A
  • 52 Week Low
  • FBIO $1.36
  • HHS $4.85
  • 52 Week High
  • FBIO $2.89
  • HHS $8.87
  • Technical
  • Relative Strength Index (RSI)
  • FBIO 33.40
  • HHS 38.02
  • Support Level
  • FBIO $1.65
  • HHS $5.31
  • Resistance Level
  • FBIO $1.85
  • HHS $5.33
  • Average True Range (ATR)
  • FBIO 0.10
  • HHS 0.19
  • MACD
  • FBIO -0.01
  • HHS -0.02
  • Stochastic Oscillator
  • FBIO 7.32
  • HHS 9.26

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

About HHS Harte-Hanks Inc.

Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.

Share on Social Networks: